No Data
No Data
JMP Securities Maintains Allogene Therapeutics(ALLO.US) With Hold Rating
JMP Securities analyst Reni Benjamin maintains $Allogene Therapeutics(ALLO.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 35.5% and a total average return of -6.
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.James Hardie Industries posted adjuste
Allogene Therapeutics Shares Jump 10% on Share Purchases by Chairman, CEO
By Denny Jacob Allogene Therapeutics shares jumped 10% on Tuesday after company insiders bought up shares, often an indication of confidence by leadership. Shares were trading around $2.83. The stoc
Insider Trading: Allogene Therapeutics' Insider Buys Shares Worth $5M
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Larimar Therapeutics, Inc.. (NASDAQ:LRMR) rose sharply in today's pre-market trading after the company announced that the FDA removed the partial clinical hold previously placed on the nomla
Allogene Therapeutics Is Maintained at Outperform by Oppenheimer
Allogene Therapeutics Is Maintained at Outperform by Oppenheimer